Core Viewpoint - A class action lawsuit has been filed against Outset Medical, Inc. for alleged violations of federal securities laws related to misleading statements about the company's products and operations [1][2][3]. Group 1: Lawsuit Details - The lawsuit seeks to recover damages for all individuals and entities that purchased Outset Medical securities between August 1, 2022, and August 7, 2024 [2]. - Allegations include that Outset Medical made materially false statements regarding the Tablo products, including marketing for unapproved uses and lacking the necessary sales infrastructure [3]. Group 2: Next Steps for Investors - Investors who suffered losses in Outset Medical have until October 28, 2024, to request to be appointed as lead plaintiff in the case [4]. - A copy of the Complaint can be reviewed on the law firm's website [4]. Group 3: Legal Representation - The law firm operates on a contingency fee basis, meaning they will only collect fees if the case is successful [5]. - Bronstein, Gewirtz & Grossman, LLC has a history of recovering significant amounts for investors in securities fraud cases [6].
OM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Outset Medical, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!